IMNN
Imunon, Inc.
There isn't enough reported data to score IMNN yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
IMNN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Unavailable | |
| Unavailable |
IMNN's revenue is currently stable, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
IMNN PE Valuation
IMNN has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
IMNN Forward outlook
There aren't enough analyst estimates for IMNN to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
IMNN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$5.26 | +$6.00 |
| Q2 2026 | -$5.78 | +$9.42 |
| Q1 2026 | -$7.39 | +$13.31 |
| Q4 2025 | -$10.75 | +$13.55 |
| Q3 2025 | -$11.26 | +$16.79 |
| Q2 2025 | -$15.20 | +$13.30 |
| Q1 2025 | -$20.70 | +$9.30 |
| Q4 2024 | -$24.30 | +$8.10 |
IMNN is still losing money, but far less than before: $5.26 per share over the past year, against $191.25 at its worst in early 2020.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over IMNN on earnings quality, reporting a profit while its opponent remains loss making.
IMNN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $125K | 0% |
| Q3 2022 | $125K | 0% |
| Q2 2022 | $125K | 0% |
| Q1 2022 | $125K | 0% |
| Q4 2021 | $125K | 0% |
| Q3 2021 | $125K | 0% |
| Q2 2021 | $125K | 0% |
| Q1 2021 | $125K | 0% |
IMNN has the stronger quarterly revenue trend. Revenue is flat for IMNN versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2022 | -5541% | -1149 points |
| Q3 2022 | -4940% | -890 points |
| Q2 2022 | -4783% | -726 points |
| Q1 2022 | -4674% | -367 points |
| Q4 2021 | -4393% | -558 points |
| Q3 2021 | -4049% | -722 points |
| Q2 2021 | -4057% | -244 points |
| Q1 2021 | -4307% | -494 points |
IMNN's operating margin was −5541% last quarter, down 1149 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
IMNN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.2M | +$1.2M |
| Q4 2025 | -$3.7M | +$775.2K |
| Q3 2025 | -$4.4M | -$382.7K |
| Q2 2025 | -$3M | +$1.5M |
| Q1 2025 | -$3.1M | +$2.8M |
| Q4 2024 | -$4.4M | -$663.6K |
| Q3 2024 | -$4.1M | +$654.4K |
| Q2 2024 | -$4.5M | +$2.3M |
IMNN has the stronger cash trend. Its trailing FCF is up 22% versus its history, compared with UNH at up 5.2%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
IMNN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +14% | +715K shares |
| 1 year | +366% | +4.7M shares |
| 3 years | +977% | +5.4M shares |
| 5 years | +3823% | +5.8M shares |
IMNN has 6M diluted shares, up 366% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over IMNN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
IMNN Net Leverage
IMNN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
IMNN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.1 | Oversold |
| Stochastic | 8.5 | Oversold |
IMNN's weekly RSI is 25 (oversold) and its Stochastic is 9 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
IMNN PE vs Healthcare Sector
IMNN has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
IMNN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.05 | 39% below |
| 20 week MA | $1.41 | 55% below |
| 50 week MA | $2.36 | 73% below |
| 100 week MA | $6.65 | 90% below |
| 200 week MA | $11.7 | 95% below |
IMNN is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over IMNN on trend strength, trading above more of its moving averages.
IMNN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $366.8 | $166.5 | -55% |
| 2021 | $166.5 | $139.5 | -16% |
| 2022 | $139.5 | $20.0 | -86% |
| 2023 | $20.0 | $10.2 | -49% |
| 2024 | $10.2 | $11.9 | +17% |
| 2025 | $11.9 | $3.15 | -74% |
| 2026 YTD | $3.15 | $0.64 | -80% |
IMNN has finished lower in five of the last six years. It's down 80% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over IMNN on returns for 2026, with the stronger performance.